MedTrace Logo

Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone

NCT03529565 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2024-09-26

No results posted yet for this study

Summary

This trial studies histamine and bone pain association in participants with breast cancer that has spread to the bone. Studying histamine levels in samples of blood from participants with breast cancer in the laboratory may help doctors learn more about reducing cancer bone pain and preventing further bone metastasis.

Conditions

  • Bone Pain
  • Breast Carcinoma Metastatic in the Bone

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of blood

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Doris Brown · Wake Forest University Health Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2024-09-18
Completion
2024-09-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03529565 on ClinicalTrials.gov